ARYA Sciences Acquisition Corp IV (ARYD)
(Delayed Data from NSDQ)
$11.35 USD
0.00 (0.00%)
Updated May 1, 2024 01:49 PM ET
NA Value
NA Growth NA Momentum NA VGMFundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
ARYD 11.35 0.00(0.00%)
Will ARYD be a Portfolio Killer in May?
Zacks Investment Research is releasing its prediction for ARYD based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ARYD
Amicus (FOLD) Stock Down on Q3 Earnings and Revenue Miss
ARYD: What are Zacks experts saying now?
Zacks Private Portfolio Services
Other News for ARYD
ARYA Sciences Acquisition IV Announces Transformative Merger
Adagio Medical to go public in $113M deal with SPAC ARYA Sciences
ARYA Sciences’ Strategic Moves Amid Business Combination Plans
Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies
Adagio Medical to be public through Arya Sciences Acquisition Corp combination